Home / GLP-1 appeals / Mounjaro / Aetna

Mounjaro denial · Aetna

Aetna denied your Mounjaro. Here is how to appeal it.

Most Aetna GLP-1 denials are winnable, if your appeal speaks to Aetna's own policy and lands before the deadline. We draft it for free, grounded in Aetna's actual coverage rules with every citation verified. You review, sign, and file it.

Check my Aetna denial, free See the strategy

Free to draft. Every citation checked against Aetna's policy before you file.

Your deadline

Often 180 days

For Aetna's first internal review. Some plans allow 60. Your denial notice controls, check it.

Most common reason

Off-label for weight loss

Mounjaro is approved for type 2 diabetes. Used for weight loss, it is often denied or sent to step therapy.

What wins

Cite the exact policy

Appeals mapped to Aetna's specific Clinical Policy Bulletin do far better than generic letters.

Why Aetna denies Mounjaro

Mounjaro (tirzepatide) is FDA-approved to improve blood sugar in adults with type 2 diabetes. It is not FDA-approved for weight loss; the same molecule is sold as Zepbound for chronic weight management. That distinction drives most Aetna denials. The common patterns:

  • Prescribed off-label for weight loss. When Mounjaro is billed without a type 2 diabetes diagnosis on the claim, Aetna commonly denies it as not covered for that use. If you do have type 2 diabetes, the fix is often making sure the diagnosis and A1c are clearly documented.
  • Step therapy (metformin first). Many Aetna plans require a documented trial of metformin or another preferred agent before a GLP-1. If your records do not show the trial or a documented intolerance, the claim is denied even when that history exists.
  • No prior authorization on file (code CO-197). Aetna's automated adjudication flags missing, expired, or mismatched authorization codes before a human reviews the claim.
  • Formulary tier or Clinical Policy Bulletin criteria. Aetna applies its own CPBs, often stricter than the label, and places drugs on tiers. A denial can mean the submitted documentation did not show the specific criteria the CPB requires.

How to win the appeal with Aetna

The pattern that works against Aetna is precision: make the medical director's job a simple checkbox match against their own policy.

The move: pull the exact Clinical Policy Bulletin Aetna used, then show, line by line, where your records meet each criterion. If you have type 2 diabetes, lead with that diagnosis and your A1c, since that is the indication Mounjaro is approved for. Appeals that map to the specific CPB language consistently outperform generic medical-necessity letters.

  • Document the type 2 diabetes diagnosis clearly: the diagnosis code, recent A1c, and treatment history. This is the FDA-approved indication and the strongest footing.
  • Answer step therapy head-on: show the prior trial of metformin or other preferred agents, with dates, or document the contraindication or intolerance that justifies skipping it.
  • Name the CPB by number on the cover sheet and answer each criterion in order, with the page of your record that proves it.
  • File within the window. Aetna's first internal review is commonly 180 days from the denial. If that is denied, you have the right to a second internal level and then an independent external review.

Sources include Aetna's published Clinical Policy Bulletins and precertification lists and the Mounjaro prescribing information. We cite the specific policy that applies to your plan when we build your appeal.

The magic is visible

Your appeal, built from Aetna's own rules. Every citation checked.

We draft from the sources below, then verify each one before you file. On our held-out testing: 0 invented citations, versus about 1 in 4 for raw AI.

  • Aetna's coverage policyThe specific Aetna Clinical Policy Bulletin and formulary rules that apply to your planVerified
  • FDA labelTirzepatide (Mounjaro) prescribing information, type 2 diabetes indication and dosingVerified
  • Your recordsYour diabetes diagnosis, A1c, and prior therapies, cited back accuratelyVerified

Let's check your Aetna denial, free.

Answer a few questions for an honest read on your odds, then your verified draft. No account, no cost.

Check my denial, free

Aetna + Mounjaro: common questions

How long do I have to appeal?
Aetna's first internal review is commonly 180 calendar days from the denial, though some plan types allow 60. Your denial notice states the deadline that applies to you, and that controls. File as early as you can.
It was denied as off-label, can I still appeal?
Yes. If you have type 2 diabetes, the appeal centers on documenting that diagnosis and your A1c, since that is Mounjaro's FDA-approved use. If it was prescribed purely for weight loss, the same molecule is FDA-approved for weight management under a different brand, and we will give you an honest read on the path.
Do I need my doctor to appeal?
You can file the appeal yourself. A strong appeal often includes a letter of medical necessity from your prescriber, but the administrative appeal is your right to submit. If a fresh clinical opinion is needed, that comes from a licensed clinician, not from us.
Is this really free?
Yes. We draft your appeal for free and you file it. No fee, no contingency, nothing taken from coverage you win. AppealIt is not a law firm and does not provide legal or medical advice.

Other Mounjaro appeals: Humana · Kaiser Permanente · UnitedHealthcare · All Mounjaro denials